Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 12

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells

Imai, Michitaka, Higuchi, Masaya, Kawamura, Hiroki, Yoshita, Manami, Takahashi, Masahiko, Oie, Masayasu, Matsuki, Hideaki, Tanaka, Yuetsu, Aoyagi, Yutaka, Fujii, Masahiro·2013·Virus Genes
DOI 10.1007/s11262-012-0831-9
Open this paper in CoChat — free account

Abstract

While human T cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T cell leukemia, a close relative, HTLV-2, is not associated with any leukemia. HTLV-1 and HTLV-2 encode the Tax1 and Tax2 proteins, respectively, which are essential for the immortalization of human T cells by the respective viruses, thereby causing persistent infection. In this study, we compared Tax1 and Tax2 with respect to their immortalization activity in human T cells. Lentivirus-mediated transduction of the tax2 gene into human peripheral blood mononuclear cells stimulated with phytohemagglutinin and interleukin-2 in 96-well plates induced outgrowing T cells in most wells, but the cells infected with the control viruses died within 3 weeks. Surprisingly, the number of outgrowing cells induced by Tax2 was much higher than that induced by Tax1, and the appearance of outgrowing cells by Tax2 was earlier than that induced by Tax1. Nevertheless, both Tax2 and Tax1 preferentially immortalized CD4(+) T cells, but not CD8(+) T cells. Our study showed that HTLV-2 Tax2 can immortalize human CD4(+) T cells, and the activity is much higher than that of Tax1. The distinct T cell immortalization activities of Tax2 and Tax1 might therefore play a role in the different pathogeneses observed for these two viruses.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11262-012-0831-9

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 33

  1. T. Uchiyama, J. Yodoi, K. Sagawa, K. Takatsuki, H. Uchino, Blood 50(3), 481–492 (1977) · DOI
  2. B.J. Poiesz, F.W. Ruscetti, A.F. Gazdar, P.A. Bunn, J.D. Minna, R.C. Gallo, Proc Natl Acad Sci USA 77(12), 7415–7419 (1980) · DOI · Paper page
  3. Y. Hinuma, H. Komoda, T. Chosa, T. Kondo, M. Kohakura, T. Takenaka, M. Kikuchi, M. Ichimaru, K. Yunoki, I. Sato, R. Matsuo, Y. Takiuchi, H. Uchino, M. Hanaoka, Int. J. Cancer 29(6), 631–635 (1982) · DOI
  4. M. Matsuoka, K. T. Jeang, Oncogene 30(12), 1379–1389 (2011) · DOI
  5. I. Miyoshi, I. Kubonishi, S. Yoshimoto, T. Akagi, Y. Ohtsuki, Y. Shiraishi, K. Nagata, Y. Hinuma, Nature 294(5843), 770–771 (1981) · DOI
  6. W.W. Hall, M. Fujii, Oncogene 24(39), 5965–5975 (2005) · DOI
  7. P. Miyazato, J. Yasunaga, Y. Taniguchi, Y. Koyanagi, H. Mitsuya, M. Matsuoka, J. Virol. 80(21), 10683–10691 (2006) · DOI · Paper page
  8. H. Hasegawa, H. Sawa, M.J. Lewis, Y. Orba, N. Sheehy, Y. Yamamoto, T. Ichinohe, Y. Tsunetsugu-Yokota, H. Katano, H. Takahashi, J. Matsuda, T. Sata, T. Kurata, K. Nagashima, W.W. Hall, Nat. Med. 12(4), 466–472 (2006) · DOI
  9. T. Ohsugi, T. Kumasaka, S. Okada, T. Urano, Nat. Med. 13(5), 527–528 (2007) · DOI
  10. M.D. Robek, L. Ratner, J. Virol. 73(6), 4856–4865 (1999) · DOI
  11. R. Grassmann, S. Berchtold, I. Radant, M. Alt, B. Fleckenstein, J.G. Sodroski, W.A. Haseltine, U. Ramstedt, J. Virol. 66(7), 4570–4575 (1992) · DOI
  12. T. Akagi, K. Shimotohno, J. Virol. 67(3), 1211–1217 (1993) · DOI
  13. V.S. Kalyanaraman, M.G. Sarngadharan, M. Robert-Guroff, I. Miyoshi, D. Golde, R.C. Gallo, Science 218(4572), 571–573 (1982) · DOI
  14. M.J. Lewis, P. Novoa, R. Ishak, M. Ishak, M. Salemi, A.M. Vandamme, M.H. Kaplan, W.W. Hall, Virology 271(1), 142–154 (2000) · DOI
  15. M. Higuchi, C. Tsubata, R. Kondo, S. Yoshida, M. Takahashi, M. Oie, Y. Tanaka, R. Mahieux, M. Matsuoka, M. Fujii, J. Virol. 81(21), 11900–11907 (2007) · DOI
  16. T. Shoji, M. Higuchi, R. Kondo, M. Takahashi, M. Oie, Y. Tanaka, Y. Aoyagi, M. Fujii, Retrovirology 6, 83 (2009) · DOI
  17. A. Niinuma, M. Higuchi, M. Takahashi, M. Oie, Y. Tanaka, F. Gejyo, N. Tanaka, K. Sugamura, L. Xie, P.L. Green, M. Fujii, J. Virol. 79(18), 11925–11934 (2005) · DOI
  18. J.P. Northrop, K.S. Ullman, G.R. Crabtree, J. Biol. Chem. 268(4), 2917–2923 (1993) · DOI
  19. K. Endo, A. Hirata, K. Iwai, M. Sakurai, M. Fukushi, M. Oie, M. Higuchi, W.W. Hall, F. Gejyo, M. Fujii, J. Virol. 76(6), 2648–2653 (2002) · DOI
  20. Y. Tanaka, A. Yoshida, H. Tozawa, H. Shida, H. Nyunoya, K. Shimotohno, Int. J. Cancer 48(4), 623–630 (1991) · DOI
  21. L. Meertens, S. Chevalier, R. Weil, A. Gessain, R. Mahieux, J. Biol. Chem. 279(41), 43307–43320 (2004) · DOI
  22. T. Akagi, H. Ono, H. Nyunoya, K. Shimotohno, Oncogene 14(17), 2071–2078 (1997) · DOI
  23. S.C. Sun, S. Yamaoka, Oncogene 24(39), 5952–5964 (2005) · DOI
  24. T.M. Ross, S.M. Pettiford, P.L. Green, J. Virol. 70(8), 5194–5202 (1996) · DOI
  25. J. Ye, L. Xie, P.L. Green, J. Virol. 77(14), 7728–7735 (2003) · DOI
  26. L. Xie, P.L. Green, J. Virol. 79(23), 14536–14545 (2005) · DOI
  27. M. Liu, L. Yang, L. Zhang, B. Liu, R. Merling, Z. Xia, C.Z. Giam, J. Virol. 82(17), 8442–8455 (2008) · DOI
  28. H. Zhi, L. Yang, Y.L. Kuo, Y.K. Ho, H.M. Shih, C.Z. Giam, PLoS Pathog. 7(4), e1002025 (2011) · DOI
  29. M. Higuchi, M. Fujii, Retrovirology 6, 117 (2009) · DOI
  30. O. Rosin, C. Koch, I. Schmitt, O.J. Semmes, K.T. Jeang, R. Grassmann, J. Biol. Chem. 273(12), 6698–6703 (1998) · DOI
  31. C. Tsubata, M. Higuchi, M. Takahashi, M. Oie, Y. Tanaka, F. Gejyo, M. Fujii, Retrovirology 2, 46 (2005) · DOI
  32. L. Xie, B. Yamamoto, A. Haoudi, O.J. Semmes, P.L. Green, Blood 107(5), 1980–1988 (2006) · DOI
  33. A. Hirata, M. Higuchi, A. Niinuma, M. Ohashi, M. Fukushi, M. Oie, T. Akiyama, Y. Tanaka, F. Gejyo, M. Fujii, Virology 318(1), 327–336 (2004) · DOI

Cited by

See all 12

Metadata

Authors
Imai, M., Higuchi, M., Kawamura, H., Yoshita, M., Takahashi, M., Oie, M., Matsuki, H., Tanaka, Y., Aoyagi, Y., & Fujii, M.
Venue
Virus Genes
Publisher
Springer Science and Business Media LLC
Published
2012-09-29
Volume
46
Issue
1
Pages
39-46
ISSN
  • 0920-8569
  • 1572-994X
DOI
10.1007/s11262-012-0831-9
Cited by
12
References
1
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells. https://app.cochat.ai/papers/10.1007/s11262-012-0831-9
The paper
Imai, M., Higuchi, M., Kawamura, H., Yoshita, M., Takahashi, M., Oie, M., Matsuki, H., Tanaka, Y., Aoyagi, Y., & Fujii, M. (2013). Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells. Virus Genes. https://doi.org/10.1007/s11262-012-0831-9